Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T-Reference-Cited by-同舟云学术

Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T

Published:2018-05-04 Issue:12 Volume:20 Page:1661-1671
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Paech Daniel¹^ORCID,Windschuh Johannes²³,Oberhollenzer Johanna¹,Dreher Constantin¹,Sahm Felix⁴⁵,Meissner Jan-Eric²,Goerke Steffen²,Schuenke Patrick²,Zaiss Moritz⁶,Regnery Sebastian⁷,Bickelhaupt Sebastian¹,Bäumer Philipp¹²,Bendszus Martin⁸,Wick Wolfgang⁹,Unterberg Andreas¹⁰,Bachert Peter,Ladd Mark Edward²¹¹,Schlemmer Heinz-Peter¹,Radbruch Alexander¹¹²

Affiliation:

1. German Cancer Research Center, Division of Radiology, Heidelberg, Germany

2. German Cancer Research Center, Division of Medical Physics in Radiology, Heidelberg, Germany

3. Department of Radiology, New York University Langone Medical Center, New York, New York, USA

4. Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany

5. CCU Neuropathology, German Consortium for Translational Cancer Research, German Cancer Research Center, Heidelberg, Germany

6. Max-Planck-Institute for Biological Cybernetics, Magnetic Resonance Center, Tuebingen, Germany

7. Department of Radiooncology, University Hospital Heidelberg, Heidelberg, Germany

8. Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany

9. Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany

10. Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany

11. Faculty of Physics and Astronomy and Faculty of Medicine, University of Heidelberg, Heidelberg, Germany

12. Department of Radiology, University Hospital Essen, Essen, Germany

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/20/12/1661/26495578/noy073.pdf

Reference50 articles.

1. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology;Porter;Neuro Oncol,2010

2. Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up;Stupp;Ann Oncol,2009

3. Malignant gliomas in adults;Wen;N Engl J Med,2008

4. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;N Engl J Med,2005

5. Concepts in glioma immunotherapy;Platten;Cancer Immunol Immunother,2016

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiparametric chemical exchange saturation transfer MRI detects metabolic changes in mild cognitive impairment cases at 3.0 Tesla.;2024-09-03

2. The Role of Amide Proton Transfer (APT)-Weighted Imaging in Glioma: Assessment of Tumor Grading, Molecular Profile and Survival in Different Tumor Components;Cancers;2024-08-29

3. Advances in diffuse glioma assessment: preoperative and postoperative applications of chemical exchange saturation transfer;Frontiers in Neuroscience;2024-07-31

4. Multi-pool chemical exchange saturation transfer MRI in glioma grading, molecular subtyping and evaluating tumor proliferation;Journal of Neuro-Oncology;2024-06-14

5. Brain tumor-associated epilepsies in adulthood: Current state of diagnostic and individual treatment options;Seizure: European Journal of Epilepsy;2024-06